This PDF is the current document as it appeared on Public Inspection on 10/24/2013 at 08:45 am.
Department of Defense (DoD).
Notice of Federal Advisory Committee meeting.
The Department of Defense is publishing this notice to announce that the following Federal Advisory Committee meeting of the Defense Health Board will take place.
Monday, November 18, 2013
8:00 a.m.-8:45 a.m. (Administrative Working Meeting)
9:00 a.m.-12:00 p.m. (Open Session)
12:00 p.m.-1:00 p.m. (Administrative Working Meeting)
1:00 p.m.-5:30 p.m. (Open Session)
Tuesday, November 19, 2013
7:15 a.m.-1:30 p.m. (Administrative Working Meeting)
Defense Health Headquarters (DHHQ), Pavilion Salons B-C, 7700 Arlington Blvd., Falls Church, Virginia 22042 (escort required; see guidance in SUPPLEMENTARY INFORMATION, “Public's Accessibility to the Meeting.”)Start Further Info
FOR FURTHER INFORMATION CONTACT:
The Director of the Defense Health Board is Ms. Christine Bader, 7700 Arlington Boulevard, Suite 5101, Falls Church, Virginia 22042, (703) 681-6653, Fax: (703) 681-9539, Christine.email@example.com. For meeting information, please contact Ms. Kendal Brown, 7700 Arlington Boulevard, Suite 5101, Falls Church, Virginia 22042, Kendal.Brown.firstname.lastname@example.org, (703) 681-6670, Fax: (703) 681-9539.End Further Info End Preamble Start Supplemental Information
This meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in accordance with section 10(a)(2) of Public Law. Additional information, including the agenda and electronic registration, is available at the DHB Web site, http://www.health.mil/dhb/meeting-2013-11-1819.cfm.
Purpose of the Meeting: The purpose of the meeting is to address and deliberate pending and new issues before the Board.
Agenda: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 102-3.165 and subject to availability of space, the DHB meeting is open to the public from 9:00 a.m. to 12:00 p.m. and 1:00 p.m. to 5:30 p.m. on November 18, 2013. On November 18, 2013, the DHB will receive briefings from the Department to include concussive care in theater, DoD's suicide prevention efforts, DoD Pharmaceutical Operations, and the Millennium Cohort Study with an overview of its findings. The Board will vote on proposed recommendations regarding the trends in overweight and obesity in America for the DoD. Additionally, the Board will receive briefings on the progress being made by the subcommittees on dual loyalties of military medical providers, the sustainment and advancement of amputee care, deployment pulmonary health, theater trauma lessons learned and Continuing Health Education.
Public's Accessibility to the Meeting: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through 102-3.165 and subject to availability of space, this meeting is open to the public. Seating is limited and is on a first-come basis. All members of the public who wish to attend the public meeting must contact Ms. Kendal Brown at the number listed in the section FOR FURTHER INFORMATION CONTACT no later than noon on Friday, November 8 to register and make arrangements for a DHHQ escort, if necessary. Public attendees requiring escort should arrive at the DHHQ Visitor's Entrance with sufficient time to complete security screening no later than 8:30 a.m. on November 18. To complete security screening, please come prepared to present two forms of identification and one must be a picture identification card.
Special Accommodations: Individuals requiring special accommodations to access the public meeting should contact Ms. Kendal Brown at least five (5) business days prior to the meeting so that appropriate arrangements can be made.
Written Statements: Any member of the public wishing to provide comments to the DHB may do so in accordance with 41 CFR 102-3.105(j) and 102-3.140 and section 10(a)(3) of the Federal Advisory Committee Act, and the procedures described in this notice.
Individuals desiring to provide comments to the DHB may do so by submitting a written statement to the DHB Designated Federal Officer (DFO) (see FOR FURTHER INFORMATION CONTACT). Written statements should address the following details: the issue, discussion, and a recommended course of action. Supporting documentation may also be included, as needed, to establish the appropriate historical context and to provide any necessary background information.
If the written statement is not received at least five (5) business days prior to the meeting, the DFO may choose to postpone consideration of the statement until the next open meeting.
The DFO will review all timely submissions with the DHB President and ensure they are provided to members of the DHB before the meeting that is subject to this notice. After reviewing the written comments, the President and the DFO may choose to invite the submitter to orally present their issue during an open portion of this meeting or at a future meeting. The DFO, in consultation with the DHB President, may allot time for members of the public to present their issues for review and discussion by the Defense Health Board.Start Signature
Dated: October 22, 2013.
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2013-25178 Filed 10-24-13; 8:45 am]
BILLING CODE 5001-06-P